In Phase A, participants will obtain distinctive doses and schedules of oral ABBV-744 pill to recognize safe dosing program. Further members will probably be enrolled with the discovered monotherapy dosign program. In Phase B, participants will obtain oral ruxolitinib and ABBV-744 might be supplied as "add-on" therapy. In Segment C, https://abbv-744combinationtherap57902.bloguetechno.com/details-fiction-and-clinical-effectiveness-of-abbv-744-in-aml-patients-67189166